Clinical trials
Rhinitis clinical trials
Below are recruiting rhinitis clinical trials, each written for real people, not researchers. We’re tracking 63 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06709092Recruiting
Testing Lupatadine for dust mite allergies
This study tests a new tablet (Lupatadine Fumarate) for people with nasal allergies caused by dust mites. It looks at how well the medicine works and what it does in the body.
Nanjing, JiangsuAges 18–65 - NCT06846385RecruitingPhase 2/Phase 3
Testing a new shot for severe seasonal hay fever
This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.
Beijing, Beijing MunicipalityAges 18–75 - NCT06890260Recruiting
Electroacupuncture plus microneedle for allergic rhinitis
This trial tests a 4-week treatment of electroacupuncture combined with microneedle knife for people with moderate to severe allergic rhinitis. It may help reduce symptoms without relying on standard allergy medications.
Hangzhou, ZhejiangAges 18–75 - NCT06890572Recruiting
Air purifiers for allergy symptoms relief
This study tests if using an air purifier at home can help reduce allergy symptoms like a stuffy or runny nose. It is for people with persistent moderate-to-severe allergic rhinitis caused by indoor allergens like dust mites or pet dander.
SeoulAges 19–60 - NCT07091357RecruitingPhase 2
Study of SHR-1819 for seasonal allergies
This trial tests an injection called SHR-1819 for people with seasonal allergic rhinitis (hay fever) that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it helps reduce allergy symptoms during pollen season.
Beijing, Beijing MunicipalityAges 18–75 - NCT07154342RecruitingPhase 3
Testing a new antibody for seasonal allergies
This trial tests an experimental antibody (IL4Rα monoclonal antibody) for people with seasonal allergic rhinitis (hay fever) that is not well controlled by standard treatments like nasal steroid sprays. The goal is to see if this new treatment can help reduce allergy symptoms during pollen season.
Wuhan, HubeiAges 18–75 - NCT07157462Recruiting
Testing a multi-strain probiotic for year-round allergies
This trial tests if a special probiotic blend can help people with year-round allergic rhinitis (nasal allergies) caused by common indoor allergens like dust mites, cat, or dog dander. Volunteers will take the probiotic daily and track their symptoms.
Strasbourg, AlyatecAges 18 years+ - NCT07219849RecruitingPhase 2
Testing a new nasal spray for seasonal allergies
This study tests a new nasal spray (ALDP001) in adults with seasonal allergies to ragweed. It aims to find the best dose and how often to use it.
Mississauga, OntarioAges 18–65 - NCT07315945Recruiting
Allergic rhinitis severity survey in ENT visits
This study is testing a questionnaire to measure how severe your allergic rhinitis (hay fever) symptoms are during your ear, nose, and throat (ENT) checkups. If you are an adult with allergic rhinitis being seen at the ENT department, you may be asked to fill out the survey to help improve care.
StrasbourgAges 18 years+ - NCT07398859RecruitingPhase 2
New injection for seasonal allergy symptoms
This study tests an investigational injection called TQH2722 combined with standard allergy therapy for seasonal allergic rhinitis (hay fever). It may help people whose allergy symptoms are not well controlled during pollen season.
Beijing, Beijing MunicipalityAges 18–75 - NCT07435714Recruiting
Helping patients choose surgery for chronic nasal swelling
This trial is testing a tool called a patient decision aid to help people with chronic hypertrophic rhinitis (long-term nasal swelling) make better choices about their surgery. You will be asked to use the aid and share your thoughts.
New Taipei CityAges 18 years+ - NCT07452380Recruiting
Dust mite allergy shot therapy for kids with rhinitis or asthma
This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.
Hangzhou, ZhejiangAges 5–18 - NCT07563439RecruitingPhase 2
PollenVax Shot for Mugwort Pollen Allergies
This study tests a new allergy shot (PollenVax) given under the skin to treat seasonal allergies caused by mugwort pollen. If you have moderate-to-severe mugwort allergies confirmed by testing, this trial may help reduce your symptoms during pollen season.
Almaty, AlmatyAges 18–65 - NCT06603935Enrolling by invitation
Digital medicine for allergic rhinitis management
This trial tests a digital platform to help manage allergic rhinitis (nasal allergies) and sinusitis. It's for adults whose symptoms are not well controlled despite treatment.
West Palm Beach, FloridaAges 18–65 - NCT06573450Recruiting
Breath test study for allergic rhinitis and asthma
This study is looking at certain substances in your breath to better understand allergic rhinitis, asthma, and the combination of both (CARAS). It could help doctors find new ways to diagnose or treat these conditions.
Henan, ZhengzhouAges 18–80 - NCT06061848RecruitingPhase 2/Phase 3
Grass pollen allergy shot with vitamin D
This study tests if adding vitamin D to a new type of allergy shot (ILIT) works better than standard allergy drops for grass pollen allergy. It may help if you have moderate to severe seasonal allergy symptoms.
LundAges 18–60 - NCT04435990RecruitingPhase 3
Allergy shots for dust mites in teens and adults
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
Santiago de Compostela, A CoruñaAges 12–65 - NCT04891237RecruitingPhase 3
Grass and olive allergy vaccine trial for teens to older adults
This Phase 3 trial tests whether an allergy treatment can reduce symptoms caused by grass and olive pollen. It also checks safety, especially for breathing and allergic reactions, in people with confirmed grass/olive allergy.
Tarancón, CuencaAges 12–65 - NCT04898283RecruitingPhase 3
Allergy shot study for grass and cypress pollen symptoms
This phase 3 trial tests a specific allergy treatment (an “immunotherapy” shot) for people whose symptoms are triggered by grass and cypress tree pollen. It aims to see if the treatment is safer and more effective at reducing allergy symptoms over time, especially for nose/eye symptoms and some people with asthma.
Valladolid, Castille and LeónAges 12–65 - NCT05287841Recruiting
Battten graft during septum and turbinate surgery
This study tests whether adding a “batten graft” during septoplasty and turbinate reduction improves nasal breathing and nasal airflow. It aims to see if the graft helps when breathing blockage is mainly from the septum, enlarged turbinates, and the outside nasal valve collapsing.
Poplar Bluff, MissouriAges 18 years+ - NCT05331170RecruitingPhase 2
Re-training the nose to change how allergies behave
This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.
Galveston, TexasAges 18–60 - NCT05448066Recruiting
Tests allergen testing to choose allergy shots
This study checks how well a newer, detailed allergy test (using specific allergen components) can guide whether you should get allergy immunotherapy (allergy shots) for things like dust mites or grass pollen. It may help patients get the right treatment plan by improving how doctors confirm what allergens are driving symptoms.
PortoAges 5 years+ - NCT06129552Recruiting
Healthy nose cells study for sinusitis insight
This study is looking at healthy people to understand how certain cells in the nose work. It will compare them to people with sinus problems to learn what goes wrong in chronic sinusitis with nasal polyps.
LeuvenAges 18 years+ - NCT06291402Recruiting
Nasal packing duration and sore throat after nose surgery
This study compares how long nasal packing stays in place after septorhinoplasty surgery and whether it affects sore throat. It may help doctors choose the best packing duration to reduce discomfort.
Tanta, EgyptAges 20–40
Hear when a new Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for rhinitis?
- Yes. Clin2 currently lists 63 recruiting rhinitis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a rhinitis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a rhinitis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.